Xiangnan Li
- Topics
- Lung Cancer Diagnosis and Treatment (19 papers)Esophageal Cancer Research and Treatment (11 papers)Tracheal and airway disorders (11 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiangnan Li
78 papers receiving 941 citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 366
- Pulmonary and Respiratory Medicine 309
- Cancer Research 215
- Surgery 214
- Oncology 187
Countries citing papers authored by Xiangnan Li
This map shows the geographic impact of Xiangnan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangnan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangnan Li more than expected).
Fields of papers citing papers by Xiangnan Li
This network shows the impact of papers produced by Xiangnan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangnan Li. The network helps show where Xiangnan Li may publish in the future.
Co-authorship network of co-authors of Xiangnan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangnan Li. A scholar is included among the top collaborators of Xiangnan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangnan Li. Xiangnan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | 26 | |
| 12 | 1 | |
| 13 | Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats. | 12 |
| 14 | 3 | |
| 15 | 19 | |
| 16 | 58 | |
| 17 | 0 | |
| 18 | 0 | |
| 19 | 47 | |
| 20 | 88 |
About Xiangnan Li
Xiangnan Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 85 papers that have together received 953 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (19 papers), Esophageal Cancer Research and Treatment (11 papers) and Tracheal and airway disorders (11 papers). The work is most often cited by research in Cancer Research (215 citations), Pulmonary and Respiratory Medicine (309 citations) and Oncology (187 citations). Xiangnan Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xue Pan, Minjie Shen, Dengyan Zhu, Dong Qiu, Hongbin Yuan, Donglei Liu, Kai Wu, Jia Zhao, Mei Yang and Yu Qi. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.